CYTOKINETICS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cytokinetics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Cytokinetics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $104M.
  • Cytokinetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $221M, a 57.1% decline from 2022.
  • Cytokinetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $516M, a 61.3% increase from 2021.
  • Cytokinetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $320M, a 36.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $221M -$295M -57.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $516M +$196M +61.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $320M +$85.9M +36.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $234M +$74.3M +46.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $160M +$147M +1117% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $13.1M -$213M -94.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $226M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2013 $14.5M -$43.8M -75.2% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-07
2012 $58.3M +$36.7M +170% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-07
2011 $21.6M +$19.1M +749% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-07
2010 $2.55M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.